Seshu Tyagarajan - 28 Nov 2022 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role: Exhibit 24 - Power of Attorney. Officer Title: Chief Technical and Development Officer
Signature: /s/ Jason Amello, as Attorney-In-Fact for Seshu Tyagarajan
Issuer symbol: CADL
Transactions as of: 28 Nov 2022
Net transactions value: $0
Form type: 4
Filing time: 30 Nov 2022, 17:26:32 UTC
Previous filing: 15 Apr 2022
Next filing: 12 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CADL	Common Stock	Award	$0	+73,684		$0.000000	73,684	28 Nov 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. 50% of the RSUs shall vest on November 28, 2023, and the remaining 50% on November 28, 2024, in each case subject to the Reporting Person's continued service on such vesting date.

Remarks:

Exhibit 24 - Power of Attorney. Officer Title: Chief Technical and Development Officer